T1	Participants 67 138	patients with non-small cell lung cancer after antiangiogenesis therapy
T2	Participants 632 729	Patients of non-small cell lung cancer (NSCLC) treated with chemotherapy with or without Endostar
T3	Participants 1968 1973	NSCLC
T4	Participants 2171 2203	antiangiogenic therapy of NSCLC.
